低分子肝素——依诺肝素在经皮冠状动脉介入治疗围手术期的应用

The application of low molecular weight heparin-enoxaparin in percutaneous coronary intervention

因肝素在用于经皮冠状动脉介入治疗的抗凝时,手术中难以监测性和可能的致血小板减少症等问题,引起了医生的顾虑。近年来,低分子肝素在这类手术中的抗凝方案已成为一个研究热点,本文综合相关文献,介绍了低分子肝素在经皮冠脉介入治疗中的使用相关问题。

Many problems such as inconvenient monitoring and heparin-induced thrombocytopenia occur in percutaneous coronary intervention when heparin is used for anticoagulation. Recently anticoagulation regimen using low molecular weight heparin in percutaneous coronary intervention has become the hot point of research. Some related literature are reviewed to introduce the application of low molecular weight heparin in percutaneous coronary intervention in this article.